BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29257976)

  • 1. Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease.
    Nido GS; Dölle C; Flønes I; Tuppen HA; Alves G; Tysnes OB; Haugarvoll K; Tzoulis C
    Neurobiol Aging; 2018 Mar; 63():120-127. PubMed ID: 29257976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA deletions in mice in men: substantia nigra is much less affected in the mouse.
    Guo X; Kudryavtseva E; Bodyak N; Nicholas A; Dombrovsky I; Yang D; Kraytsberg Y; Simon DK; Khrapko K
    Biochim Biophys Acta; 2010; 1797(6-7):1159-62. PubMed ID: 20388490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease.
    Bender A; Krishnan KJ; Morris CM; Taylor GA; Reeve AK; Perry RH; Jaros E; Hersheson JS; Betts J; Klopstock T; Taylor RW; Turnbull DM
    Nat Genet; 2006 May; 38(5):515-7. PubMed ID: 16604074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased mitochondrial DNA deletions in substantia nigra dopamine neurons of the aged rat.
    Parkinson GM; Dayas CV; Smith DW
    Curr Aging Sci; 2014; 7(3):155-60. PubMed ID: 25612740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant Twinkle increases dopaminergic neurodegeneration, mtDNA deletions and modulates Parkin expression.
    Song L; Shan Y; Lloyd KC; Cortopassi GA
    Hum Mol Genet; 2012 Dec; 21(23):5147-58. PubMed ID: 22949510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detrimental deletions: mitochondria, aging and Parkinson's disease.
    Biskup S; Moore DJ
    Bioessays; 2006 Oct; 28(10):963-7. PubMed ID: 16998822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism.
    Song L; McMackin M; Nguyen A; Cortopassi G
    Neurobiol Dis; 2017 Apr; 100():30-38. PubMed ID: 28042097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease.
    Dölle C; Flønes I; Nido GS; Miletic H; Osuagwu N; Kristoffersen S; Lilleng PK; Larsen JP; Tysnes OB; Haugarvoll K; Bindoff LA; Tzoulis C
    Nat Commun; 2016 Nov; 7():13548. PubMed ID: 27874000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders.
    Gu G; Reyes PE; Golden GT; Woltjer RL; Hulette C; Montine TJ; Zhang J
    J Neuropathol Exp Neurol; 2002 Jul; 61(7):634-9. PubMed ID: 12125742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Mitochondrial Genome Analysis by Massively Parallel Sequencing.
    Palculict ME; Zhang VW; Wong LJ; Wang J
    Methods Mol Biol; 2016; 1351():3-17. PubMed ID: 26530670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature of mitochondrial DNA deletions in substantia nigra neurons.
    Reeve AK; Krishnan KJ; Elson JL; Morris CM; Bender A; Lightowlers RN; Turnbull DM
    Am J Hum Genet; 2008 Jan; 82(1):228-35. PubMed ID: 18179904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA alterations as ageing-associated molecular events.
    Wei YH
    Mutat Res; 1992 Sep; 275(3-6):145-55. PubMed ID: 1383757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related human mtDNA deletions: a heterogeneous set of deletions arising at a single pair of directly repeated sequences.
    Baumer A; Zhang C; Linnane AW; Nagley P
    Am J Hum Genet; 1994 Apr; 54(4):618-30. PubMed ID: 8128959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease.
    Simon DK; Lin MT; Zheng L; Liu GJ; Ahn CH; Kim LM; Mauck WM; Twu F; Beal MF; Johns DR
    Neurobiol Aging; 2004 Jan; 25(1):71-81. PubMed ID: 14675733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons.
    Kraytsberg Y; Kudryavtseva E; McKee AC; Geula C; Kowall NW; Khrapko K
    Nat Genet; 2006 May; 38(5):518-20. PubMed ID: 16604072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions.
    Bender A; Schwarzkopf RM; McMillan A; Krishnan KJ; Rieder G; Neumann M; Elstner M; Turnbull DM; Klopstock T
    J Neurol; 2008 Aug; 255(8):1231-5. PubMed ID: 18604467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of deletions flanked by short direct repeats in mitochondrial DNA of aging Drosophila.
    Yui R; Matsuura ET
    Mutat Res; 2006 Feb; 594(1-2):155-61. PubMed ID: 16289600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial DNA rearrangements in health and disease--a comprehensive study.
    Damas J; Samuels DC; Carneiro J; Amorim A; Pereira F
    Hum Mutat; 2014 Jan; 35(1):1-14. PubMed ID: 24115352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine metabolism drives generation of mitochondrial DNA deletions in dopaminergic neurons.
    Neuhaus JF; Baris OR; Hess S; Moser N; Schröder H; Chinta SJ; Andersen JK; Kloppenburg P; Wiesner RJ
    Brain; 2014 Feb; 137(Pt 2):354-65. PubMed ID: 24163249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.